ArticleArchives of rheumatology2024

Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study.

Tumay Ak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.